Council for Responsible Nutrition-The Science Behind the Supplements

| Members Only | Join CRN |

What's New

Challenges in 2012 for the Dietary Supplement Industry
—CRN's Duffy MacKay posts for CRN's new blog, Doing the Right Thing, on Nutraceuticals World

CRN Says Law Provides Balance of Supplement Safety and Access for Consumers—Responds to NEJM Article on Supplement Industry Regulation

CRN Elects New Board Members, Committee Chairs

CRN Begins New Year With Six New Members

CRN Submits Comments to FDA on Citizen Petition to Require Cautionary Statements On the Label of Dietary Supplements Containing St. John’s Wort (PDF)

CRN and VIRGO Announce Webinar to Examine GMP Compliance—FDA Representatives and Industry Experts to Review Key Elements of Successful Inspections

Dietary Supplement Industry Calls for Overhaul of FDA's NDI Draft Guidance

CRN Calls for FDA's Withdrawal of NDI Draft Guidance

CRN Submits Comments to FDA on New Dietary Ingredient Draft Guidance (PDF)

CRN Names Rend Al-Mondhiry Regulatory Counsel

CRN Submits Comments to Office of Government Ethics on Federal Employees Attendance at Trade Association Events

CRN to Educate Pharmacists on Dietary Supplement Regulation
—Association to present webinar via new social media community

"NDI Draft Guidance: How Did We Get Here?" by CRN's Steve Mister and John Hathcock in Nutritional Outlook

CRN Seeks Director, Communications

CRN Commissions Legal Analyses of Potential WTO Violations Related to Health Claims and Nutrient Maximums

CRN Submits Comments to FDA on Health Claims for Phytosterols and Risk of Coronary Heart Disease, Proposed Rule, Reopening of the Comment Period (PDF)

CRN President Steve Mister's Opening Remarks from
'The Workshop: CRN's Day of Science' (PDF)

CRN Names Carl Hyland Director of Membership Development

CRN Reacts to JAMA's SELECT Trial on Vitamin E

CRN Calls New Study on Supplements and Mortality "A Hunt for Harm"

NEW CRN Backgrounder: FDA Draft Guidance on New Dietary Ingredients for the Dietary Supplement Industry

Top Lawyer Questions Legal Merits of NDI Draft Guidance—CRN/VIRGO Webinar Pairs FDA Representativs with Industry experts to Discuss Controversial Document

CRN Welcomes Two New Members

CRN Reacts to JAMA Study on Saw Palmetto

CRN's Open Letter in Response to a Commentary in JAMA Regarding Dietary Supplement Regulation

UPDATED: White Paper on FDA's Statutory Authority to Regulate Dietary Supplements

CRN Submits Comments to OMB on Premarket Notification for a New Dietary Ingredient

CRN Supports Increased Funding for FDA